Triple antiplatelet therapy consisting of cilostazol added to clopidogrel and aspirin does not improve clinical outcomes in patients who receive drug-eluting stents (DES) compared with standard dual ...
ATLANTA – Patients implanted with stents may have improved platelet activity when assigned to a triple antiplatelet therapy regimen compared with a dual-antiplatelet therapy regimen, study results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback